| Experimental groups |
Cells scored/rat |
Structural chromosomal aberrations |
Total structure aberrations |
Frequency of aberrant cells(%) |
| Gaps |
Isochromatid gaps |
Breaks |
Fragments |
| I |
312/6 |
9 |
3 |
9 |
4 |
25 |
7.05±1.55b |
| II |
309/6 |
7 |
4 |
6 |
3 |
20 |
6.52±1.02b |
| III |
304/6 |
13 |
4 |
10 |
7 |
34 |
11.86±0.93c |
| IV |
302/6 |
2 |
0 |
1 |
1 |
4 |
0.99±0.44a |
| V |
311/6 |
12 |
11 |
9 |
10 |
42 |
14.39±0.96c |
Group-I, Ochratoxin A (4 ppm in feed); Group-II, Endosulfan (5 mg/kg body weight); Group-III, Ochratoxin A+ Endosulfan (4 ppm in feed + 5 mg/kg body weight); Group-IV,
Control; Group-V, Cyclophosphamide (20 mg/kg body weight by interperitoneal route); Values are expressed as Mean ± SE (n = 6); Values with different superscript letters
within columns represent significant statistical differences (P ≤ 0.01). |
